All companies
Visit website
ONEFUL HEALTH, INC.
OperatingOneFul Health, Inc.
Healthcare · Founded 2013
Making medicines work better for you
Post-money valuation ⓘ
$9.8M
As of Apr 2024 · from OneFul Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$75,804
Across 2 rounds since 2023
Latest share price
$1.00
OneFul Common Stock 1 offering price
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source$7.2M
−$471K
2020
$5.8M
$120K
2021
$3.9M
−$503K
2022
$2.6M
−$239K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$7,187,789
$5,843,237
$3,937,387
$2,550,893
Cost of goods sold
$4,417,454
$2,904,204
$1,782,680
$410,293
Gross margin
39%
50%
55%
84%
Net income
-$471,495
$119,595
-$503,111
-$239,111
Taxes paid
$0
$0
$10,231
$14,379
Balance sheet
Cash
$147,073
$347,297
$242,225
$66,160
Accounts receivable
$201,391
$128,876
$133,375
$119,758
Total assets
$1,378,616
$1,221,140
$874,165
$723,972
Short-term debt
$0
$0
$53,790
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$0
$53,790
$0
Other
Headcount
—
22
22
22
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$11.6M
post-money
$9.8M
post-money
OneFul Health, Inc. Common Stock 1
OneFul Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $23.6K / $536.5KPost-money $9.8M
Raised $52.2K / $1.2MInvestors 76Post-money $11.6M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
76 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001605753Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.